Zobrazeno 1 - 2
of 2
pro vyhledávání: '"On Behalf Of The Synapse Study Group, On Behalf Of The Synapse Study Group"'
Autor:
C, Bachert, P W, Hellings, V J, Lund, W J, Fokkens, C, Hopkins, B, Mayer, R H, Chan, S G, Smith, A R, Sousa, R, Alfonso-Cristancho, S, Yang, On Behalf Of The Synapse Study Group, On Behalf Of The Synapse Study Group
Publikováno v:
Rhinology, 60(6), 474-478. University Hospital Utrecht
Mepolizumab improves quality of life and reduces activity impairments in patients with CRSwNP. ispartof: RHINOLOGY vol:60 issue:6 ispartof: location:Netherlands status: published
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b408d2c45441c5318a997c7bcf0dd9c4
https://doi.org/10.4193/rhin22.053
https://doi.org/10.4193/rhin22.053
Autor:
Bachert C; Ghent University and Ghent University Hospital, Belgium; University of Stockholm, Stockholm, Sweden., Hellings PW; Ghent University and Ghent University Hospital, Belgium; University of Leuven, Leuven, Belgium; Academic Medical Center, Amsterdam, the Netherlands., Lund VJ; University College London, London, UK; Royal National Throat Nose and Ear Hospital, UCLH, London, UK., Fokkens WJ; Academic Medical Center, Amsterdam, the Netherlands., Hopkins C; Guys and St Thomas' Hospital, King's College, London, UK., Mayer B; Clinical Statistics, GSK, GSK House, Brentford, Middlesex, UK., Chan RH; Respiratory Patient-Centred Outcomes, Value Evidence and Outcomes, GSK, Brentford, Middlesex, UK., Smith SG; Respiratory Therapeutic Area, GSK, Research Triangle Park, NC, USA., Sousa AR; Respiratory Patient-Centred Outcomes, Value Evidence and Outcomes, GSK, Brentford, Middlesex, UK., Alfonso-Cristancho R; Respiratory Therapeutic Area, GSK, Research Triangle Park, NC, USA., Yang S; Value Evidence and Outcomes, GSK, Collegeville, PA, USA., On Behalf Of The Synapse Study Group OBOTSSG
Publikováno v:
Rhinology [Rhinology] 2022 Dec 01; Vol. 60 (6), pp. 474-478.